APA

van den Berg J. H., Oosterhuis K., Hennink W. E., Storm G., van der Aa L. J., Engbersen J. F. J., Haanen J. B. A. G., Beijnen J. H., Schumacher T. N. & Nuijen B. (20100402). Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. : Journal of controlled release : official journal of the Controlled Release Society.

Chicago

van den Berg Joost H, Oosterhuis Koen, Hennink Wim E, Storm Gert, van der Aa Leonardus J, Engbersen Johan F J, Haanen John B A G, Beijnen Jos H, Schumacher Ton N and Nuijen Bastiaan. 20100402. Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. : Journal of controlled release : official journal of the Controlled Release Society.

Harvard

van den Berg J. H., Oosterhuis K., Hennink W. E., Storm G., van der Aa L. J., Engbersen J. F. J., Haanen J. B. A. G., Beijnen J. H., Schumacher T. N. and Nuijen B. (20100402). Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. : Journal of controlled release : official journal of the Controlled Release Society.

MLA

van den Berg Joost H, Oosterhuis Koen, Hennink Wim E, Storm Gert, van der Aa Leonardus J, Engbersen Johan F J, Haanen John B A G, Beijnen Jos H, Schumacher Ton N and Nuijen Bastiaan. Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. : Journal of controlled release : official journal of the Controlled Release Society. 20100402.